BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31633647)

  • 1. Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and to define their diagnostic roles in current scenario.
    Arora S; Kumar R; Passah A; Tripathi M; Agarwala S; Khadgawat R; Bal C
    Nucl Med Commun; 2019 Dec; 40(12):1230-1242. PubMed ID: 31633647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Url C; Riechelmann H; Sprinzl GM; Thomé C; Treglia G; Kjaer A; Fraedrich G; Virgolini IJ
    Nucl Med Biol; 2019 Apr; 71():47-53. PubMed ID: 31152973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
    Jing H; Li F; Wang L; Wang Z; Li W; Huo L; Zhang J
    Clin Nucl Med; 2017 Jul; 42(7):525-529. PubMed ID: 28481789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.
    Kroiss A; Shulkin BL; Uprimny C; Frech A; Gasser RW; Url C; Gautsch K; Madleitner R; Nilica B; Sprinzl GM; Gastl G; Fraedrich G; Virgolini IJ
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):33-41. PubMed ID: 25134670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study.
    Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B
    Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
    Maurice JB; Troke R; Win Z; Ramachandran R; Al-Nahhas A; Naji M; Dhillo W; Meeran K; Goldstone AP; Martin NM; Todd JF; Palazzo F; Tan T
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1266-70. PubMed ID: 22526961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compared to
    Kroiss AS; Uprimny C; Shulkin BL; Frech A; Tilg H; Gasser RW; Sprinzl GM; Gruber L; Thomé C; Plangger C; Url C; Fraedrich G; Virgolini IJ
    Ann Nucl Med; 2017 Jun; 31(5):357-365. PubMed ID: 28349331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of Somatostatin Receptor Scintigraphy (Tc-[HYNIC, Tyr3]-Octreotide) and 123I-Metaiodobenzylguanidine Scintigraphy in Patients with SDHx Gene-Related Pheochromocytomas and Paragangliomas Detected by Computed Tomography.
    Michałowska I; Ćwikła JB; Pęczkowska M; Furmanek MI; Buscombe JR; Michalski W; Prejbisz A; Szperl M; Malinoc A; Moczulski D; Szutkowski Z; Kawecki A; Antoniewicz J; Pęczkowski P; Lewczuk A; Otto M; Cichocki A; Bednarek-Tupikowska G; Kabat M; Janaszek-Sitkowska H; Przybyłowska K; Janas J; Neumann HP; Januszewicz A
    Neuroendocrinology; 2015; 101(4):321-30. PubMed ID: 25791839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma.
    Rufini V; Treglia G; Castaldi P; Perotti G; Calcagni ML; Corsello SM; Galli G; Fanti S; Giordano A
    Nucl Med Commun; 2011 Jul; 32(7):575-82. PubMed ID: 21471850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
    Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Eisenhofer G; King KS; Rao JU; Wesley RA; Adams KT; Pacak K
    J Natl Cancer Inst; 2012 May; 104(9):700-8. PubMed ID: 22517990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 123I-MIBG Scintigraphy in Paraganglioma.
    Milardovic R; Corssmit EP; Stokkel M
    Neuroendocrinology; 2010; 91(1):94-100. PubMed ID: 19786729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utility of
    Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 131I-MIBG, 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT scans in a patient with extra adrenal paraganglioma associated with SDH-B gene mutation.
    Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
    Clin Nucl Med; 2015 May; 40(5):439-41. PubMed ID: 25742231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours.
    Naji M; Zhao C; Welsh SJ; Meades R; Win Z; Ferrarese A; Tan T; Rubello D; Al-Nahhas A
    Mol Imaging Biol; 2011 Aug; 13(4):769-75. PubMed ID: 20700766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of ⁶⁸Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study.
    Naswa N; Sharma P; Nazar AH; Agarwal KK; Kumar R; Ammini AC; Malhotra A; Bal C
    Eur Radiol; 2012 Mar; 22(3):710-9. PubMed ID: 21971823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
    Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
    Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Comparative Study of 18 F-FDOPA PET/CT Versus 123 I-MIBG Scintigraphy With SPECT/CT for the Diagnosis of Pheochromocytoma and Paraganglioma.
    Sung C; Lee HS; Lee DY; Kim YI; Kim JE; Lee SJ; Oh SJ; Sung TY; Lee YM; Kim YH; Kim BJ; Koh JM; Lee SH; Ryu JS
    Clin Nucl Med; 2024 Jan; 49(1):27-36. PubMed ID: 38054497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.